This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $1,801.80 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat type 2 diabetes. The contract has a ceiling value of $1,351.35 and runs through February 12, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a $3,652.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat type 2 diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a firm fixed-price structure and a ceiling value of $2,452.33, with an ultimate completion date of May 21, 2025. The contract is not set aside for any specific business type....
This is a $3,700.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of June 13, 2025 and is not set aside for a specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat type 2 diabetes. The contract has a ceiling value of $3,408.58 and a completion date of October 27, 2023. The contract type is Firm Fixed Price. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat type 2 diabetes. The contract has a ceiling value of $4,089.56 and a period of performance through January 31, 2025. It is a firm fixed price contract, with no set-aside requirements indicated....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,765.12 contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a period of performance through June 10, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a large indefinite delivery contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,975.48, is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 14, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription diabetes medication. The delivery order has a value of $1,815.42 and a completion date of July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which provides a mechanism...